Guido Schachschal1, Susanne Sehner2, Matthias Choschzick3,4, Daniela Aust5, Lydia Brandl6, Michael Vieth7, Karl Wegscheider2, Gustavo B Baretton5, Thomas Kirchner6, Guido Sauter3, Thomas Rösch8. 1. Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Martinistr 52, 20246, Hamburg, Germany. 2. Department of Medical Biometry and Epidemiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. 3. Department of Pathology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. 4. Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland. 5. Department of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany. 6. Institute of Pathology, Ludwig-Maximilian University, Munich, Germany. 7. Institute of Pathology, Bayreuth Hospital, Bayreuth, Germany. 8. Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Martinistr 52, 20246, Hamburg, Germany. t.roesch@uke.de.
Abstract
BACKGROUND: Recommended follow-up intervals after endoscopic removal of hyperplastic polyps (HP) and sessile serrated adenomas (SSA) differ because of assumed differences in biological behaviour. However, histopathologic differentiation is difficult, with higher SSA rates reported from specialist GI histopathologists. OBJECTIVE: The objective of this study was to clarify the relevance of histologic reassessment of HP. DESIGN AND SETTING: From a prospective screening colonoscopy study relevant serrated lesions (excluding distal small HP ≤5 mm) diagnosed by private practice pathologists were reassessed by four specialized GI pathologists PATIENTS: One thousand sixty-nine screening colonoscopies were performed in patients. MAIN OUTCOME MEASUREMENTS: In terms of main outcome measurements, there is a likelihood of changes of the HP diagnosis on reassessment, as well as interrater variability. RESULTS: SSA were initially diagnosed in 7 cases (0.7%) and relevant HP in 83 (7.8%; 101 lesions). Of the latter, the chance of a change in diagnosis from HP to SSA by any of the four specialist histopathologists was higher for larger (>5 mm) and right-sided lesions (19.1 vs 1.3%, OR 18.4, p = 0.04) including a higher likelihood to change recommended follow-up intervals (32.1 vs 3.3%, p < 0.01). However, follow-up intervals were determined by concomitant adenomas in 41%. Interrater variability was also higher for these lesions (p = 0.04), with an overall kappa value of 0.48. However, this issue related to only 1.2% of the 1069 study cases. LIMITATION: The limitations this study are the limited case number as well as limited retrospective assessment. CONCLUSIONS: Right-sided HP >5 mm had a higher chance of change in diagnosis to SSA; therefore, they should probably be treated like adenomas and be removed. However, reliable data for recommendations on follow-up intervals of HP or SSA will require follow-up studies.
BACKGROUND: Recommended follow-up intervals after endoscopic removal of hyperplastic polyps (HP) and sessile serrated adenomas (SSA) differ because of assumed differences in biological behaviour. However, histopathologic differentiation is difficult, with higher SSA rates reported from specialist GI histopathologists. OBJECTIVE: The objective of this study was to clarify the relevance of histologic reassessment of HP. DESIGN AND SETTING: From a prospective screening colonoscopy study relevant serrated lesions (excluding distal small HP ≤5 mm) diagnosed by private practice pathologists were reassessed by four specialized GI pathologists PATIENTS: One thousand sixty-nine screening colonoscopies were performed in patients. MAIN OUTCOME MEASUREMENTS: In terms of main outcome measurements, there is a likelihood of changes of the HP diagnosis on reassessment, as well as interrater variability. RESULTS: SSA were initially diagnosed in 7 cases (0.7%) and relevant HP in 83 (7.8%; 101 lesions). Of the latter, the chance of a change in diagnosis from HP to SSA by any of the four specialist histopathologists was higher for larger (>5 mm) and right-sided lesions (19.1 vs 1.3%, OR 18.4, p = 0.04) including a higher likelihood to change recommended follow-up intervals (32.1 vs 3.3%, p < 0.01). However, follow-up intervals were determined by concomitant adenomas in 41%. Interrater variability was also higher for these lesions (p = 0.04), with an overall kappa value of 0.48. However, this issue related to only 1.2% of the 1069 study cases. LIMITATION: The limitations this study are the limited case number as well as limited retrospective assessment. CONCLUSIONS: Right-sided HP >5 mm had a higher chance of change in diagnosis to SSA; therefore, they should probably be treated like adenomas and be removed. However, reliable data for recommendations on follow-up intervals of HP or SSA will require follow-up studies.
Entities:
Keywords:
Histopathological second opinion; Hyperplastic polyps; Screening colonoscopy; Serrated lesions
Authors: Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church Journal: Am J Gastroenterol Date: 2012-06-19 Impact factor: 10.864
Authors: Kevin J Spring; Zhen Zhen Zhao; Rozemary Karamatic; Michael D Walsh; Vicki L J Whitehall; Tanya Pike; Lisa A Simms; Joanne Young; Michael James; Grant W Montgomery; Mark Appleyard; David Hewett; Kazutomo Togashi; Jeremy R Jass; Barbara A Leggett Journal: Gastroenterology Date: 2006-08-18 Impact factor: 22.682
Authors: Suryakanth R Gurudu; Russell I Heigh; Giovanni De Petris; Evelyn G Heigh; Jonathan A Leighton; Shabana F Pasha; Isaac B Malagon; Ananya Das Journal: World J Gastroenterol Date: 2010-07-21 Impact factor: 5.742
Authors: Hermann Brenner; Lutz Altenhofen; Jens Kretschmann; Thomas Rösch; Christian Pox; Christian Stock; Michael Hoffmeister Journal: Gastroenterology Date: 2015-04-22 Impact factor: 22.682
Authors: Khaled Abdeljawad; Krishna C Vemulapalli; Charles J Kahi; Oscar W Cummings; Dale C Snover; Douglas K Rex Journal: Gastrointest Endosc Date: 2014-07-03 Impact factor: 9.427
Authors: A J McCarthy; S M O'Reilly; J Shanley; R Geraghty; E J Ryan; G Cullen; K Sheahan Journal: Gastroenterol Res Pract Date: 2019-02-06 Impact factor: 2.260
Authors: Madhav Desai; Joseph C Anderson; Michael Kaminski; Viveksandeep Thoguluva Chandrasekar; Jihan Fathallah; Cesare Hassan; David Lieberman; Prateek Sharma Journal: Endosc Int Open Date: 2021-04-13